Alcobra Ltd.
(NASDAQ : ADHD)

( )
ADHD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ADHD News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-2.58%16.6414.2%$377.84m
SHPGShire PLC Sponsored ADR
-0.85%171.910.4%$214.79m
PRXLPAREXEL International Corporation
-0.05%87.017.9%$147.08m
PRGOPerrigo Co. Plc
-1.53%74.706.4%$144.76m
MNKMallinckrodt Plc
-3.01%44.8517.7%$120.76m
ALRAlere Inc.
0.04%50.232.7%$93.61m
JAZZJazz Pharmaceuticals Plc
-2.48%154.862.2%$85.33m
PTLAPortola Pharmaceuticals, Inc.
-4.39%54.418.9%$84.74m
UTHRUnited Therapeutics Corporation
-1.64%130.9413.9%$75.70m
ENDPEndo International Plc
-3.98%11.348.9%$71.85m
HZNPHorizon Pharma plc
-4.58%11.477.6%$55.69m
ICPTIntercept Pharmaceuticals, Inc.
-6.37%122.0122.1%$50.98m
MDCOMedicines Company
-2.21%38.0322.3%$48.56m
CTLTCatalent Inc
-2.64%35.752.8%$41.75m
SAGESAGE Therapeutics, Inc.
-7.34%76.0111.9%$36.05m

Company Profile

Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.,00F9JC-E